Louis‐David Cantin
AstraZeneca (Canada)(CA)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Asymmetric Synthesis and Catalysis, HIV/AIDS drug development and treatment, Organophosphorus compounds synthesis, Synthesis and Catalytic Reactions
Most-Cited Works
- → Mitigating the Inhibition of Human Bile Salt Export Pump by Drugs: Opportunities Provided by Physicochemical Property Modulation, In Silico Modeling, and Structural Modification(2012)84 cited
- → Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s(2012)71 cited
- → Design, Synthesis, and Biological Evaluation of Monopyrrolinone-Based HIV-1 Protease Inhibitors(2003)61 cited
- → Virtual Screening and Computational Optimization for the Discovery of Covalent Prolyl Oligopeptidase Inhibitors with Activity in Human Cells(2012)56 cited
- → The synthesis of enantiomerically pure, symmetrically substituted cyclopropane phosphonic acids — A constrained analog of the GABA antagonist phaclophen(1997)52 cited
- → The synthesis of enantiomerically pure disubstituted aziridines and N-alkoxy aziridines(2000)38 cited
- → In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii(1993)37 cited
- → PDE-10A inhibitors as insulin secretagogues(2007)35 cited
- → Discovery of P2X3 selective antagonists for the treatment of chronic pain(2012)30 cited
- → Design and synthesis of MMP inhibitors using N -arylsulfonylaziridine hydroxamic acids as constrained scaffolds(2001)22 cited